274 related articles for article (PubMed ID: 19127950)
1. Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina.
Garcia-Bournissen F; Altcheh J; Giglio N; Mastrantonio G; Della Védova CO; Koren G
Paediatr Drugs; 2009; 11(1):33-7. PubMed ID: 19127950
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review.
Arrúa EC; Seremeta KP; Bedogni GR; Okulik NB; Salomon CJ
Acta Trop; 2019 Oct; 198():105080. PubMed ID: 31299283
[TBL] [Abstract][Full Text] [Related]
3. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
[TBL] [Abstract][Full Text] [Related]
4. Current and developing therapeutic agents in the treatment of Chagas disease.
Apt W
Drug Des Devel Ther; 2010 Sep; 4():243-53. PubMed ID: 20957215
[TBL] [Abstract][Full Text] [Related]
5. [Changes in parasitemia evaluated using the modified Strout method in patients with acute Chagas disease under treatment].
Castro C; Emanuel A
Rev Soc Bras Med Trop; 1988; 21(4):177-80. PubMed ID: 3152133
[No Abstract] [Full Text] [Related]
6. Potential new clinical therapies for Chagas disease.
Bustamante JM; Tarleton RL
Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
[TBL] [Abstract][Full Text] [Related]
7. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
[No Abstract] [Full Text] [Related]
8. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
[TBL] [Abstract][Full Text] [Related]
9. Experimental and Clinical Treatment of Chagas Disease: A Review.
Sales Junior PA; Molina I; Fonseca Murta SM; Sánchez-Montalvá A; Salvador F; Corrêa-Oliveira R; Carneiro CM
Am J Trop Med Hyg; 2017 Nov; 97(5):1289-1303. PubMed ID: 29016289
[TBL] [Abstract][Full Text] [Related]
10. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
11. Current status of Chagas disease chemotherapy.
Guedes PM; Silva GK; Gutierrez FR; Silva JS
Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270
[TBL] [Abstract][Full Text] [Related]
12. [Allopurinol in the treatment of chronic Chagas' disease].
Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
[No Abstract] [Full Text] [Related]
13. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].
Sosa Estani S; Segura EL
Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259
[TBL] [Abstract][Full Text] [Related]
14. Current drug therapy and pharmaceutical challenges for Chagas disease.
Bermudez J; Davies C; Simonazzi A; Real JP; Palma S
Acta Trop; 2016 Apr; 156():1-16. PubMed ID: 26747009
[TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal agents: treatment or threat?
Issa VS; Bocchi EA
Lancet; 2010 Sep; 376(9743):768; author reply 768-9. PubMed ID: 20816538
[No Abstract] [Full Text] [Related]
16. Treatment with Fenofibrate plus a low dose of Benznidazole attenuates cardiac dysfunction in experimental Chagas disease.
Cevey ÁC; Mirkin GA; Donato M; Rada MJ; Penas FN; Gelpi RJ; Goren NB
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):378-387. PubMed ID: 29040909
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery for chagas disease: A viewpoint.
Kratz JM
Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074
[TBL] [Abstract][Full Text] [Related]
18. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).
Castro JA; de Mecca MM; Bartel LC
Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919
[TBL] [Abstract][Full Text] [Related]
19. [Nifurtimox, a bright future for treatment of Chagas disease].
Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
[TBL] [Abstract][Full Text] [Related]
20. Long-term cardiology outcomes in children after early treatment for Chagas disease, an observational study.
González NL; Moscatelli G; Moroni S; Ballering G; Jurado L; Falk N; Bochoeyer A; Goldsman A; Grippo M; Freilij H; Garcia Bournissen F; Chatelain E; Altcheh J
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010968. PubMed ID: 36534647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]